By inhibiting TNF-α-induced adhesion molecules, it exerts anti-inflammatory effects, and via binding to the transcription factor peroxisome proliferator-activated receptor-α, it activates downstream pathways which improve, among others, insulin resistance, hypertension, and obesity [81,82,83]. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.